Literature DB >> 9751248

Uric acid in chronic heart failure: a measure of the anaerobic threshold.

F Leyva1, T P Chua, S D Anker, A J Coats.   

Abstract

The anaerobic threshold (AT) is a measure of the balance between aerobic and anaerobic cellular metabolism. Hyperuricemia occurs in conditions that involve an imbalance between cellular oxygen consumption and carbon dioxide production, such as chronic heart failure (CHF). We therefore hypothesized that in CHF, serum uric acid might be related to the AT. Patients with CHF (n=40, aged 58.7+/-1.9 years; New York Heart Association Class I-IV; maximal oxygen consumption [MVO2], 18.7+/-01.1 mL/kg/min; left ventricular ejection fraction, 26%+/-2%) and 10 age-matched healthy controls underwent measurement of the serum uric acid level at rest and assessment of the AT. This was derived from MVO2 and the regression slope relating minute ventilation to carbon dioxide output (VE - VCO2) during a maximal treadmill exercise test. Compared with the healthy controls, patients with CHF had a lower AT (11.8+/-0.7 v 16.9+/-1.1 mL/kg/min, P < .001) and a higher serum uric acid concentration (493.8+/-22.4 v 308.7+/-21.5 micromol/L, P < .001). In univariate analyses of the CHF group, the AT correlated with serum uric acid (r=-.56, P < .001; AT=19.93 - (0.016 x uric acid), R2=.31, P < .001) and plasma creatinine (r=-.43, P < .01), but not with the diuretic dose. In stepwise regression analyses of the CHF group, serum uric acid emerged as a predictor of the AT (standardized coefficient=-.56, P < .001), whereas the diuretic dose and plasma creatinine failed to enter into the final models (multiple R2=.31, P < .001). In conclusion, in CHF there is an inverse relationship between the AT and the resting serum uric acid concentration. This is consistent with the known links between uric acid production and the imbalance in aerobic/anaerobic metabolism that occur in CHF. These findings provide the basis for using the simple measurement of the serum uric acid level as a surrogate measure of the AT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751248     DOI: 10.1016/s0026-0495(98)90293-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

Review 1.  [Percutaneous aortic valve replacement - pro].

Authors:  Lutz Buellesfeld; Eberhard Grube
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

2.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

3.  Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure.

Authors:  Hyoung-Seob Park; Hyungseop Kim; Ji-Hyun Sohn; Hong-Won Shin; Yun-Kyeong Cho; Hyuck-Jun Yoon; Chang-Wook Nam; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim; Hee-Joon Park
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 2.884

4.  The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study.

Authors:  Devyani Misra; Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2011-03-24       Impact factor: 5.532

5.  Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients.

Authors:  Camilla Hage; Erik Michaëlsson; Bengt Kull; Tasso Miliotis; Sara Svedlund; Cecilia Linde; Erwan Donal; Jean-Claude Daubert; Li-Ming Gan; Lars H Lund
Journal:  ESC Heart Fail       Date:  2020-05-19

Review 6.  Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.

Authors:  Andrea Tedeschi; Piergiuseppe Agostoni; Beatrice Pezzuto; Ugo Corra'; Domenico Scrutinio; Rocco La Gioia; Rosa Raimondo; Andrea Passantino; Massimo F Piepoli
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

Review 7.  Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review.

Authors:  Marko Kumrić; Josip A Borovac; Tina Tičinović Kurir; Joško Božić
Journal:  Life (Basel)       Date:  2021-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.